SHIVA Trial: France’s Big Shot at Precision Medicine for Cancer
SHIVA01 and SHIVA02 are large-scale trials run in France to evaluate the efficacy of precision…
20/07/2017 - 5 minutes
SHIVA01 and SHIVA02 are large-scale trials run in France to evaluate the efficacy of precision…
Personalized medicine would be nothing without genomic testing tools. Here's an overview of how the field…
The RAIDs consortium made its closing event last week. After 4.5 years of studies, it…
Immuno-oncology is definitely the most promising breakthrough in cancer research right now. But the main…
Curie-Cancer, the part responsible for developing Institut Curie’s industry partnership activities, and GamaMabs Pharma, a company specialized in…